Clinical trial · Observational
Pediatric PET/MR Image Registry
NCT03458520CI-TRIAL-00102829recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to compare whole body magnetic resonance (MR) imaging, whole body positron emission tomography (PET)/MR imaging, and (if available) PET/Computed Tomography (CT) imaging for the diagnosis of tumors in children and young adults. Sensitivities, specificities and diagnostic accuracies of the different imaging modalities will be compared for significant differences.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lymphoma | Lymphoma | ONTOLOGY_EXACT | 0.90 |
| Osteosarcoma | Osteosarcoma | ONTOLOGY_EXACT | 0.90 |
| Soft Tissue | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MR imaging | Diagnostic Test | — | UNRESOLVED |
| PET/CT imaging | Diagnostic Test | — | UNRESOLVED |
| PET/MR imaging | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Image Registry
- description
- patients with proven solid tumors or newly diagnosed mass strongly suspected to represent a solid tumor will receive MR imaging, PET/MR imaging (and if available, PET/CT imaging)
- interventionNames
- Diagnostic Test: PET/MR imaging
- Diagnostic Test: MR imaging
- Diagnostic Test: PET/CT imaging
Primary outcomes (1)
- measure
- Number of tumors
- timeFrame
- up to 12 months
- description
- Number of tumors detected on whole body MRI, PET/MR and (if available) PET/CT scans.
Secondary outcomes (1)
- measure
- Metabolic activity of tumors
- timeFrame
- up to 12 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Maximum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with proven solid tumors or newly diagnosed mass strongly suspected to represent a solid tumor. * We might also include some patients with leukemia if there is concern for a focal lesion in any of their organs. * Participant's parents (if participant is under 18) or the participant (if participant is 18 years or older) must willingly give written informed consent prior to any image transfer to the image registry. Exclusion Criteria: * Patient has contraindications for MRI or PET/MR. This includes patients with cardiac pacemakers or intracranial vascular clips as well as patients with a blood glucose level \> 200 mg/dl. * Lack of parental permission (if participant is younger than 18) or lack of informed consent (if participant is at least 18 years of age). * Patient has a CNS primary tumor. * Pregnant women and fetuses
References
Publications (0)
Data not yet available
No reference posted for this study.